FBXW11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.036200E-01
Normal-vs-Stage2
5.470200E-01
Normal-vs-Stage3
1.407780E-02
Normal-vs-Stage4
8.780600E-01
Stage1-vs-Stage2
2.252400E-01
Stage1-vs-Stage3
4.157800E-02
Stage1-vs-Stage4
9.558800E-01
Stage2-vs-Stage3
1.437410E-01
Stage2-vs-Stage4
3.591600E-01
Stage3-vs-Stage4
9.577900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.516000E-01
Normal-vs-AfricanAmerican
8.495000E-01
Normal-vs-Asian
5.810600E-01
Caucasian-vs-AfricanAmerican
5.491600E-01
Caucasian-vs-Asian
7.155200E-01
AfricanAmerican-vs-Asian
4.110800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.584600E-01
Normal-vs-Female
6.156800E-01
Male-vs-Female
7.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.814200E-01
Normal-vs-Age(41-60Yrs)
7.708800E-01
Normal-vs-Age(61-80Yrs)
5.083800E-01
Normal-vs-Age(81-100Yrs)
1.473980E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.269800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.446800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.342300E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.433900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.50100000001685E-06
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.515900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.912200E-01
Normal-vs-Daily Drinker
2.272600E-01
Normal-vs-Weekly Drinker
2.740600E-01
Normal-vs-Occasional Drinker
9.245800E-01
Normal-vs-Social Drinker
9.715200E-01
Non Drinker-vs-Daily Drinker
6.682800E-01
Non Drinker-vs-Weekly Drinker
7.677200E-01
Non Drinker-vs-Occasional Drinker
4.897800E-02
Non Drinker-vs-Social Drinker
1.080230E-01
Daily Drinker-vs-Weekly Drinker
9.462200E-01
Daily Drinker-vs-Occasional Drinker
3.712400E-02
Daily Drinker-vs-Social Drinker
7.883700E-02
Weekly Drinker-vs-Occasional Drinker
8.541700E-02
Weekly Drinker-vs-Social Drinker
1.463030E-01
Occasional Drinker-vs-Social Drinker
8.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.397600E-01
Normal-vs-Grade 2
7.744400E-03
Normal-vs-Grade 3
6.875200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.029600E-01
Grade 1-vs-Grade 3
5.477400E-01
Grade 1-vs-Grade 4
1.397600E-01
Grade 2-vs-Grade 3
9.116200E-01
Grade 2-vs-Grade 4
7.744400E-03
Grade 3-vs-Grade 4
6.875200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.378600E-01
Normal-vs-NonDiabetic
7.031200E-01
Diabetic-vs-NonDiabetic
1.558420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.337400E-01
Normal-vs-NoPancreatitis
6.638000E-01
Pancreatitis-vs-NoPancreatitis
5.099600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.858200E-01
Normal-vs-N1
5.399400E-01
N0-vs-N1
2.736800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.033800E-01
Normal-vs-TP53-NonMutant
8.576600E-01
TP53-Mutant-vs-TP53-NonMutant
1.620850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
